Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06708728

Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases.

And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Hemolytic Anemia Anemia Anemia, Hemolytic Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine Sohag University

Sohag, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older.
  • Patients diagnosed with acquired hemolytic anemia.
  • Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period
  • Patients (or their legal representatives) must provide informed

Exclusion criteria

  • Patients with underlying neoplastic diseases.
  • Patients with hereditary hemolytic anemia.
  • Patients or their representatives who do not consent to participate in the study.

Treatment and study plan

Blood Samples

Other

blood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests

Primary outcomes

  1. intensive care unit admission of the patients due to progression of the disease complications.

    Time frame: through study completion, an average of 6 months

    Primary outcome will be ICU admission due to progression of the disease complications.

Secondary outcomes

  1. mortality within duration of hospital admission

    Time frame: through study completion, an average of 6 months

    Secondary outcome will be mortality within duration of hospital admission

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed E Mahmoud

CONTACT

[email protected]

02 01145943157

Mahmoud I Yousef, Lecturer of Internal Medicine

CONTACT

02 0106 596 4083

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 27, 2024
Registry last updated
Nov 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.